Your browser is no longer supported. Please, upgrade your browser.
BCR C. R. Bard, Inc. monthly Stock Chart
BCR [NYSE]
C. R. Bard, Inc.
IndexS&P 500 P/E39.07 EPS (ttm)7.87 Insider Own0.50% Shs Outstand73.10M Perf Week-0.25%
Market Cap22.46B Forward P/E23.79 EPS next Y12.91 Insider Trans-35.36% Shs Float72.33M Perf Month21.41%
Income590.40M PEG3.41 EPS next Q2.84 Inst Own90.30% Short Float0.80% Perf Quarter26.32%
Sales3.78B P/S5.94 EPS this Y297.20% Inst Trans-0.65% Short Ratio0.63 Perf Half Y42.24%
Book/sh22.87 P/B13.44 EPS next Y9.61% ROA11.20% Target Price299.67 Perf Year39.83%
Cash/sh12.18 P/C25.22 EPS next 5Y11.46% ROE35.30% 52W Range203.63 - 309.16 Perf YTD36.77%
Dividend1.04 P/FCF54.49 EPS past 5Y13.80% ROI17.30% 52W High-0.61% Beta0.65
Dividend %0.34% Quick Ratio1.20 Sales past 5Y5.10% Gross Margin62.80% 52W Low50.89% ATR3.47
Employees16300 Current Ratio1.50 Sales Q/Q7.50% Oper. Margin20.60% RSI (14)76.91 Volatility0.57% 0.70%
OptionableYes Debt/Eq1.05 EPS Q/Q54.30% Profit Margin15.60% Rel Volume1.15 Prev Close307.55
ShortableYes LT Debt/Eq0.68 EarningsApr 26 AMC Payout12.70% Avg Volume920.42K Price307.26
Recom2.90 SMA200.36% SMA5012.74% SMA20029.78% Volume1,062,318 Change-0.09%
Apr-25-17Downgrade Raymond James Strong Buy → Mkt Perform
Jan-05-17Upgrade Raymond James Outperform → Strong Buy $265
Jan-03-17Upgrade Morgan Stanley Equal-Weight → Overweight $240 → $260
Sep-16-16Upgrade Wells Fargo Market Perform → Outperform
Jul-27-16Reiterated Deutsche Bank Hold $234 → $240
Jul-27-16Reiterated Barclays Equal Weight $224 → $235
Jul-08-16Downgrade BofA/Merrill Buy → Neutral
May-24-16Reiterated Barclays Equal Weight $212 → $224
Apr-28-16Reiterated Barclays Equal Weight $195 → $212
Mar-17-16Initiated Nomura Neutral
Nov-12-15Initiated Citigroup Buy
Aug-27-15Upgrade Goldman Neutral → Buy
Apr-24-15Reiterated Barclays Equal Weight $175 → $185
Jan-30-15Reiterated Barclays Equal Weight $150 → $175
Jun-18-14Downgrade Barclays Overweight → Equal Weight $155 → $150
Mar-06-14Reiterated Barclays Overweight $150 → $160
Jan-09-14Reiterated Barclays Overweight $140 → $150
Oct-23-13Reiterated Barclays Overweight $135 → $140
Sep-04-13Initiated Needham Hold
Jul-24-13Reiterated Barclays Overweight $112 → $125
May-22-17 10:32AM  Becton, Dickinson and Company -- Moody's assigns Ba1 to Becton Dickinson's senior unsecured notes related to Bard Moody's
May-15-17 06:48PM  Lifshitz & Miller LLP Announces Investigation of C. R. Bard, Inc., HCSB Financial Corp., Home Capital Group Inc., Paragon Commercial Corporation, PCM, Inc., Pingtan Marine Enterprise Ltd. and United States Steel Corporation PR Newswire
03:21PM  ETFs with exposure to C.R. Bard, Inc. (New Jersey) : May 15, 2017 Capital Cube
09:13AM  CR Bard (BCR) Hits a 52-Week High: What's Driving the Stock? Zacks
May-09-17 06:18PM  Becton, Dickinson and Company -- Moody's Assigns Ba1 to Becton Dickinson's Exchange Notes Moody's
May-02-17 03:44PM  ETFs with exposure to C.R. Bard, Inc. (New Jersey) : May 2, 2017 Capital Cube
12:11PM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Whether the Sale of C. R. Bard, Inc. to Becton, Dickinson and Company for $317 Per Share is Fair to Shareholders - BCR Business Wire
May-01-17 10:39AM  C.R. Bard, Inc. (New Jersey) :BCR-US: Earnings Analysis: Q1, 2017 By the Numbers : May 1, 2017 Capital Cube
Apr-30-17 06:00AM  INVESTOR ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of C.R. Bard, Inc. And Encourages Shareholders To Contact The Firm For Additional Information Business Wire
Apr-28-17 12:40PM  Five CNBC IQ 100 components are hitting lifetime highs CNBC Videos
Apr-27-17 04:39PM  INVESTOR ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Whether the Sale of C. R. Bard, Inc. to Becton, Dickinson and Company for $317 Per Share is Fair to Shareholders - BCR PR Newswire
01:35PM  C.R. Bard, Inc. (New Jersey) : BCR-US: Dividend Analysis : May 01st, 2017 (record date) : By the numbers : April 27, 2017 Capital Cube
09:07AM  How BD-Bard Acquisition Will Strengthen International Presence Market Realist
09:04AM  3 Best Performing Stocks of April Motley Fool
07:37AM  How the BD-Bard Deal Will Create Shareholder Value Market Realist
Apr-26-17 05:41PM  SHAREHOLDER ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of C.R. Bard, Inc. And Encourages Investors To Contact The Firm For Additional Information Business Wire
01:35PM  C.R. Bards Business Profile and the BD-Bard Deal Rationale Market Realist
12:05PM  A Look at BDs Deal Rationale in Its C.R. Bard Acquisition Market Realist
11:13AM  Which Companies Are Now Outperforming 95% Of All Stocks? Investor's Business Daily
11:10AM  Medical Device Maker Bolts Higher On Earnings In Massive Volume Investor's Business Daily
10:30AM  BD to Acquire C.R. Bard: Deal Highlights and Market Reaction Market Realist
Apr-25-17 01:10PM  C. R. Bard Stock Trades Ex-Dividend Thursday Investopedia
12:54PM  WeissLaw LLP: The C. R. Bard, Inc. and Becton, Dickson and Company Merger May Not Be in the Best Interests of BCR Unitholders PR Newswire
09:41AM  C.R. BARD INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of C.R. Bard, Inc. PR Newswire
09:03AM  Analysts' Actions -- Amazon, C.R. Bard, CyrusOne, Dow and More TheStreet.com
08:15AM  Blog Coverage Becton, Dickinson and C. R. Bard Set to Merge in a $24 Billion Deal Accesswire
12:36AM  [$$] Dont Succumb to Sticker Shock on Becton Dickinson Deal The Wall Street Journal
Apr-24-17 06:44PM  Tax cuts not driving this rally CNBC Videos +19.50%
06:37PM  Cramer: Trump tax cuts are not the driving force behind t... CNBC Videos
06:11PM  Cramer: Trump tax cuts are not the driving force behind this rally CNBC
06:01PM  Why C.R. Bard Shares Skyrocketed 19.5% Today Motley Fool
04:42PM  Endless Loop: Becton Dickinson Drops 4.4% on C.R. Bard Acquisition Barrons.com
04:32PM  Why C.R. Bard, Deutsche Bank, and Sonic Jumped Today Motley Fool
04:29PM  Becton Dickinson To Buy Medical Tech Firm C.R. Bard For $24 Billion Investor's Business Daily
04:28PM  Endless Loop: C.R. Bard Soars 20% on Becton Dickinson Acquisition Barrons.com
04:07PM  Harwood Feffer LLP Announces Investigation of C. R. Bard, Inc. PR Newswire
01:19PM  [$$] Don't Succumb to Sticker Shock on Becton Dickinson Deal The Wall Street Journal
12:09PM  C.R. BARD, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout Business Wire
12:04PM  C. R. Bard, Inc. Shareholder Alert: Former SEC Attorney Willie Briscoe Investigates Merger with Becton, Dickinson and Co. Business Wire
12:03PM  Story Stocks from Briefing.com Briefing.com
10:54AM  Global Markets Surge On French Runoff Election Vote And Heavy Deal News Forbes
10:43AM  Jim Cramer on Becton Dickinson's Purchase of Bard TheStreet.com
10:26AM  Behind the $24 billion medical device deal CNBC Videos
10:24AM  Stock Market News for April 24, 2017 Zacks
10:18AM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Whether the Sale of C. R. Bard, Inc. to Becton, Dickinson and Company for $317 Per Share is Fair to Shareholders - BCR Accesswire
09:19AM  A $24 Billion Megadeal to Cheer About Bloomberg
08:42AM  C.R. Bard (BCR) Beats Q1 Earnings & Revenues, FY17 View Up Zacks
07:53AM  Becton Dickinson Acquires Medical Technology Peer C.R. Bard for Hefty Premium TheStreet.com
07:03AM  Wall Street's M&A Chatter From April 21: Becton Dickinson-CR Bard, Sinclair-Bonten Media, Gannett-SweetIQ Analytics Benzinga
07:01AM  5 Things You Must Know Before the Market Opens Monday TheStreet.com
05:01AM  C.R. Bard tops Street 1Q forecasts Associated Press
12:01AM  Becton Dickinson to Acquire C.R. Bard for $24 Billion The Wall Street Journal
Apr-23-17 10:23PM  Becton, Dickinson and Company -- Moody's places Becton's Baa2/P-2 ratings on review for downgrade Moody's
09:23PM  Act Now - Shareholder Alert: Monteverde & Associates PC Announces An Investigation Of C.R. Bard, Inc. - BCR PR Newswire
07:47PM  Becton Dickinson to Buy C.R. Bard for $24 Billion The Wall Street Journal
06:51PM  Medical tech firm Becton Dickinson to buy C.R. Bard for $24B Associated Press
05:07PM  Bard Announces First Quarter Results Business Wire
05:05PM  BD Announces Appointment Of Tom Polen As President PR Newswire
05:04PM  BD To Acquire Bard For $24 Billion PR Newswire
Apr-21-17 10:35AM  Is a Surprise in Store for C.R. Bard (BCR) in Q1 Earnings? Zacks
Apr-19-17 04:15PM  Bard Declares Quarterly Dividend Business Wire
Apr-10-17 02:28PM  C.R. Bard Just Keeps Going and Going... TheStreet.com
Apr-03-17 12:15PM  Bard to Host Earnings Conference Call on April 26, 2017 Business Wire
Mar-21-17 09:30AM  Zacks.com featured highlights: East West Bancorp, CBRE Group, Colliers International Group, C.R. Bard and Primerica Zacks
Mar-20-17 09:53AM  Bet on These 5 GARP Stocks for Solid Returns
Mar-16-17 12:14PM  C.R. Bard, Inc. (New Jersey) : BCR-US: Dividend Analysis : January 23rd, 2017 (record date) : By the numbers : March 16, 2017 Capital Cube
12:14PM  C.R. Bard, Inc. (New Jersey) : BCR-US: Dividend Analysis : January 23rd, 2017 (record date) : By the numbers : March 16, 2017
Mar-13-17 11:48AM  New highs for the CNBC IQ 100 CNBC Videos
Mar-09-17 10:40AM  C. R. Bard (BCR) Well Poised for Growth, Macro Woes Remain Zacks
Mar-08-17 01:49PM  C.R. Bard, Inc. (New Jersey) :BCR-US: Earnings Analysis: Q4, 2016 By the Numbers : March 8, 2017 Capital Cube
01:49PM  C.R. Bard, Inc. (New Jersey) :BCR-US: Earnings Analysis: Q4, 2016 By the Numbers : March 8, 2017
Mar-07-17 10:30AM  Bard to Present at Barclays Global Healthcare Conference Business Wire
Mar-02-17 08:04AM  C.R. Bard (BCR) Up 8.2% Since Earnings Report: Can It Continue? Zacks
Feb-27-17 03:29PM  Go With the Upside on C.R. Bard TheStreet.com
03:29PM  Go With the Upside on C.R. Bard
11:00AM  Bard to Present at Cowen and Company Healthcare Conference Business Wire
Feb-17-17 01:04PM  BARD C R INC /NJ/ Financials
Feb-13-17 05:16PM  BARD C R INC /NJ/ Files SEC form 10-K, Annual Report
Feb-03-17 09:30AM  The Zacks Analyst Blog Highlights: C. R. Bard, Illinois Tool Works, Sherwin-Williams, Cintas and S&P Global
Feb-02-17 12:27PM  ETFs with exposure to C.R. Bard, Inc. (New Jersey) : February 2, 2017
Feb-01-17 07:21AM  C. R. Bard (BCR): Moving Average Crossover Alert
Jan-30-17 10:09AM  C.R. Bard, Inc. (New Jersey) :BCR-US: Earnings Analysis: 2016 By the Numbers : January 30, 2017
Jan-27-17 09:27AM  C.R. Bard (BCR) Q4 Earnings & Sales Better Than Expected +5.24%
Jan-26-17 05:00PM  C R Bard Inc Earnings Call scheduled for 5:00 pm ET today
04:36PM  C.R. Bard tops Street 4Q forecasts
04:20PM  BARD C R INC /NJ/ Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibit
04:15PM  Bard Announces Fourth Quarter Results Business Wire
07:07AM  Q4 2016 C R Bard Inc Earnings Release - After Market Close
Jan-25-17 07:09AM  Medical Product Stocks' Earnings on Jan 26: ABMD, BCR, ABAX
Jan-23-17 08:53AM  C.R. Bard (BCR) to Report Q4 Earnings: A Surprise in Store?
Jan-19-17 02:25PM  C. R. Bard Stock Trades Ex-Dividend Thursday at Investopedia
Jan-05-17 07:04AM  C.R. Bard upgraded by Raymond James
Jan-04-17 10:30AM  Bard to Host Earnings Conference Call on January 26, 2017 Business Wire
07:35AM  BDs Latest Dividend Payment and Capital Allocation Strategy
Jan-03-17 01:42PM  C.R. Bard: High Growth, Low Risk? at Barrons.com
10:30AM  Bard to Present at J. P. Morgan Healthcare Conference Business Wire
Dec-23-16 09:21AM  What Do Analysts Recommend for Baxter International?
06:22AM  BARD C R INC /NJ/ Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Stat
Dec-14-16 04:15PM  Bard Declares Quarterly Dividend Business Wire
Dec-13-16 10:20AM  C.R. Bard, Inc. (New Jersey) Value Analysis (NYSE:BCR) : December 13, 2016
C. R. Bard, Inc., together with its subsidiaries, designs, manufactures, packages, distributes, and sells medical, surgical, diagnostic, and patient care devices worldwide. The company offers vascular products, such as percutaneous transluminal angioplasty catheters, chronic total occlusion catheters, guidewires, fabrics, meshes, introducers, and accessories; valvuloplasty balloons; peripheral vascular stents, self-expanding and balloon-expandable covered stents, and vascular grafts; vena cava filters; biopsy devices; and a range of minimally invasive devices for the treatment of peripheral vascular and end-stage renal diseases. It also provides urology products, including Foley catheters to reduce the rate of urinary tract infections; fecal incontinence products; brachytherapy devices and radioactive seeds for the treatment of prostate cancer; intermittent urinary drainage catheters, and urine monitoring and collection systems; ureteral stents; specialty devices for stone removal procedures; surgical slings and pelvic floor repair products; catheter stabilization devices; and products for therapeutic hypothermia. In addition, the company offers oncology products, such as specialty vascular access catheters and ports, vascular access ultrasound devices, dialysis access catheters, and enteral feeding devices to treat and manage various cancers, and other diseases and disorders. Further, it provides surgical specialty products comprising implanted grafts and fixation devices for hernia and soft tissue repairs; and hemostats and surgical sealants, as well as irrigation, wound drainage, and original equipment manufacturers' products. The company sells its products directly to hospitals, individual healthcare professionals, extended care facilities, and alternate site facilities through hospital/surgical supply and other medical specialty distributors. C. R. Bard, Inc. was founded in 1907 and is headquartered in Murray Hill, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
WHITE TONY LDirectorMay 16Option Exercise83.471,200100,16815,213May 18 11:06 AM
Lupisella Frank JrVice President and ControllerApr 24Sale304.003,6221,101,08810,139Apr 25 05:24 PM
Beasley Jim CGroup PresidentFeb 21Option Exercise186.434,390818,40626,625Feb 22 03:37 PM
Beasley Jim CGroup PresidentFeb 21Sale245.004,3901,075,55022,235Feb 22 03:37 PM
WEILAND JOHN HVice Chairman, Pres. and COOFeb 14Sale240.4914,0913,388,80942,896Feb 15 04:58 PM
Groetelaars John PGroup PresidentFeb 14Sale240.49732176,04018,963Feb 15 04:58 PM
Collins Timothy PGroup PresidentFeb 14Sale240.503,768906,18626,646Feb 15 04:58 PM
DeFord John ASr. VP Sci Tech and Clin AfrsFeb 14Sale240.512,788670,55219,530Feb 15 04:58 PM
Beasley Jim CGroup PresidentFeb 14Sale240.523,213772,79622,235Feb 15 04:58 PM
Luboff Sharon MGroup Vice PresidentFeb 14Sale240.533,659880,09520,718Feb 15 04:58 PM
HOLLAND CHRISTOPHER SSenior Vice President and CFOFeb 14Sale240.53618148,64626,922Feb 15 04:58 PM
RING TIMOTHY MChairman and CEOFeb 14Sale240.5014,4253,469,16973,965Feb 15 04:58 PM
Luboff Sharon MGroup Vice PresidentFeb 13Option Exercise86.151,00086,14528,813Feb 14 03:21 PM
WEILAND JOHN HVice Chairman, Pres. and COOFeb 13Sale240.001,274305,75868,759Feb 14 03:20 PM
Collins Timothy PGroup PresidentFeb 13Sale240.30642154,27333,873Feb 14 03:20 PM
RING TIMOTHY MChairman and CEOFeb 13Sale240.021,767424,118102,139Feb 14 03:20 PM
HOLLAND CHRISTOPHER SSenior Vice President and CFOFeb 13Sale240.09642154,13628,140Feb 14 03:20 PM
Groetelaars John PGroup PresidentFeb 13Sale240.04450108,01820,362Feb 14 03:20 PM
DeFord John ASr. VP Sci Tech and Clin AfrsFeb 13Sale240.07469112,59424,662Feb 14 03:20 PM
Beasley Jim CGroup PresidentFeb 13Sale240.10734176,23027,652Feb 14 03:21 PM
Luboff Sharon MGroup Vice PresidentFeb 13Sale240.241,478355,08127,335Feb 14 03:21 PM
Larson Betty DVP - Human ResourcesFeb 10Sale240.923,292793,1108,399Feb 13 03:11 PM
Beasley Jim CGroup PresidentFeb 09Sale239.588,5932,058,67428,917Feb 10 06:23 PM
HOLLAND CHRISTOPHER SSenior Vice President and CFOFeb 09Sale239.577,5971,819,98029,405Feb 10 06:23 PM
RING TIMOTHY MChairman and CEOFeb 09Sale239.5620,3244,868,880105,618Feb 10 06:23 PM
Luboff Sharon MGroup Vice PresidentFeb 09Sale239.595,8011,389,87428,221Feb 10 06:23 PM
Collins Timothy PGroup PresidentFeb 09Sale238.987,6021,816,73835,138Feb 10 06:23 PM
DeFord John ASr. VP Sci Tech and Clin AfrsFeb 09Sale239.585,8161,393,38725,548Feb 10 06:23 PM
Groetelaars John PGroup PresidentFeb 09Sale239.665,5041,319,08621,248Feb 10 06:23 PM
Khichi Samrat S.Sr. VP, Gen Counsel & Secy.Feb 09Sale239.605,8271,396,12916,332Feb 10 06:23 PM
WEILAND JOHN HVice Chairman, Pres. and COOFeb 09Sale239.5414,2813,420,93271,131Feb 10 06:23 PM
Naughton Gail KDirectorJan 31Sale236.2236786,6941,620Feb 01 09:31 AM
Groetelaars John PGroup PresidentJan 11Sale235.00573134,65516,554Jan 12 12:05 PM
Lupisella Frank JrVice President and ControllerJan 10Sale232.002,735634,52011,603Jan 11 04:14 PM
Lupisella Frank JrVice President and ControllerJan 09Sale232.0021048,72014,338Jan 11 04:14 PM
Beasley Jim CGroup PresidentDec 30Option Exercise168.874,709795,18527,378Jan 03 02:52 PM
Lupisella Frank JrVice President and ControllerDec 30Sale226.0023753,56214,520Jan 03 02:52 PM
Beasley Jim CGroup PresidentDec 30Sale225.004,7091,059,52522,669Jan 03 02:52 PM
Luboff Sharon MGroup Vice PresidentDec 12Option Exercise86.156,000516,87029,837Dec 14 12:09 PM
WEILAND JOHN HVice Chairman, Pres. and COODec 12Option Exercise97.6911,1901,093,09572,780Dec 14 12:10 PM
Beasley Jim CGroup PresidentDec 12Option Exercise116.9711,9221,394,54434,591Dec 14 12:11 PM
DeFord John ASr. VP Sci Tech and Clin AfrsDec 12Option Exercise131.7712,5911,659,05534,198Dec 13 06:51 PM
DeFord John ASr. VP Sci Tech and Clin AfrsDec 12Sale218.8212,5912,755,13221,607Dec 13 06:51 PM
Beasley Jim CGroup PresidentDec 12Sale219.6411,9222,618,56322,669Dec 14 12:11 PM
WEILAND JOHN HVice Chairman, Pres. and COODec 12Sale219.6711,1902,458,05861,590Dec 14 12:10 PM
Luboff Sharon MGroup Vice PresidentDec 12Sale219.006,0001,314,00023,837Dec 14 12:09 PM
DeFord John ASr. VP Sci Tech and Clin AfrsDec 09Option Exercise186.433,292613,71124,899Dec 13 06:51 PM
DeFord John ASr. VP Sci Tech and Clin AfrsDec 09Sale215.003,292707,78021,607Dec 13 06:51 PM
HOLLAND CHRISTOPHER SSenior Vice President and CFOOct 28Option Exercise95.993,971381,17629,689Oct 31 04:34 PM
HOLLAND CHRISTOPHER SSenior Vice President and CFOOct 28Sale211.125,7241,208,43323,965Oct 31 04:34 PM
RING TIMOTHY MChairman and CEOSep 28Option Exercise84.5837,2933,154,055133,323Sep 29 04:14 PM
RING TIMOTHY MChairman and CEOSep 28Sale227.3437,2938,478,14096,030Sep 29 04:14 PM
RING TIMOTHY MChairman and CEOSep 27Option Exercise84.7255,0004,659,717151,030Sep 29 04:14 PM
RING TIMOTHY MChairman and CEOSep 27Sale228.1355,00012,547,09996,030Sep 29 04:14 PM
RING TIMOTHY MChairman and CEOSep 26Option Exercise86.1555,0004,737,975151,030Sep 27 04:05 PM
RING TIMOTHY MChairman and CEOSep 26Sale227.9955,00012,539,47096,030Sep 27 04:05 PM
RING TIMOTHY MChairman and CEOSep 23Option Exercise86.1555,0004,737,975151,030Sep 27 04:05 PM
RING TIMOTHY MChairman and CEOSep 23Sale229.9255,00012,645,62496,030Sep 27 04:05 PM
Larson Betty DVP - Human ResourcesSep 19Option Exercise149.064,032601,01010,298Sep 20 03:24 PM
Larson Betty DVP - Human ResourcesSep 19Sale225.334,032908,5246,266Sep 20 03:24 PM
Khichi Samrat S.Sr. VP, Gen Counsel & Secy.Sep 06Option Exercise145.839,1831,339,15722,023Sep 08 09:43 AM
DeFord John ASr. VP Sci Tech and Clin AfrsSep 06Option Exercise151.817,9281,203,55029,535Sep 08 09:43 AM
DeFord John ASr. VP Sci Tech and Clin AfrsSep 06Sale221.067,9281,752,58421,607Sep 08 09:43 AM
Khichi Samrat S.Sr. VP, Gen Counsel & Secy.Sep 06Sale221.019,1832,029,52012,840Sep 08 09:43 AM
HOLLAND CHRISTOPHER SSenior Vice President and CFOMay 27Option Exercise95.993,970381,08031,306Jun 01 12:51 PM
HOLLAND CHRISTOPHER SSenior Vice President and CFOMay 27Sale219.893,970872,94527,336Jun 01 12:51 PM